Characterization of S. pneumoniae pneumonia-induced multiple organ dysfunction syndrome: An experimental mouse model of gram-positive sepsis

Shock

Volumn 31, Issue 4, 2009, Pages 423-428

  Andonegui, Graciela ^a   Goring, Kim ^a   Liu, Dan ^a   McCafferty, Donna Marie ^b   Winston, Brent W ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Inflammation; Innate immunity; Neutrophil infiltration; Pneumococcal infection; Sepsis

Indexed keywords

CREATININE; MYELOPEROXIDASE; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BLOOD FLOW; BLOOD LEVEL; C57BL 6 MOUSE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CREATININE BLOOD LEVEL; EXPERIMENTAL MODEL; GRAM POSITIVE SEPSIS; HEART FUNCTION; HEART OUTPUT; HEART STROKE VOLUME; INTESTINE EPITHELIUM; ISOLATED HEART; KIDNEY FUNCTION; LUNG INFECTION; MALE; MORTALITY; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; PNEUMONIA; SEPSIS; STREPTOCOCCUS PNEUMONIAE; UREA BLOOD LEVEL;

ANIMALS; DISEASE MODELS, ANIMAL; GRAM-POSITIVE BACTERIAL INFECTIONS; HEART; INTESTINAL MUCOSA; LUNG; MALE; MICE; MICE, INBRED C57BL; MULTIPLE ORGAN FAILURE; MYOCARDIUM; PEROXIDASE; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; SYNDROME;

EID: 64849092026     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e318188c273     Document Type: Article

References (33)

1. Minino AM, Heron MP, Murphy SL, Kochanek KD: Deaths: final data for 2004. Natl Vital Slat Rep 55:1-119, 2007.
2. File TM Jr: Streptococcus pneumoniae and community-acquired pneumonia: a cause for concern. Am J Med 117(suppl 3A):39S-50S, 2004.
3. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20: 864-874, 1992.
4. Dremsizov T, Clermont G, Kellum JA, Kalassian KG, Fine MJ, Angus DC: Severe sepsis in community-acquired pneumonia: when does it happen, and do systemic inflammatory response syndrome criteria help predict course? Chest 129:968-978, 2006.
5. Moine P, Vercken JB, Chevret S, Chastang C, Gajdos P: Severe communityacquired pneumonia. Etiology, epidemiology, and prognosis factors. French Study Group for community-acquired pneumonia in the intensive care unit. Chest 105:1487-1495, 1994.
6. Angus DC, Marrie TJ, Obrosky DS, Clermont G, Dremsizov TT, Coley C, Fine MJ, Singer DE, Kapoor WN: Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria. Am J Respir Crit Care Med 166:717-723, 2002.
7. Kaplan V, Angus DC, Griffin MF, Clermont G, Scott WR, Linde-Zwirble WT: Hospitalized community-acquired pneumonia in the elderly: age- and sexrelated patterns of care and outcome in the United States. Am J Respir Crit Care Med 166:766-772, 2002.
8. Ewig S, Torres A: Severe community-acquired pneumonia. Clin Chest Med 20:575-587, 1999.
9. Leroy O, Santre C, Beuscart C, Georges H, Guery B, Jacquier JM, Beaucaire G: A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit. Intensive Care Med 21:24-31, 1995.
10. Andes D, Craig WA: In vivo activities of amoxicillin and amoxicillinclavulanate against Streptococcus pneumoniae: application to breakpoint determinations. Antimicrob Agents Chemother 42:2375-2379, 1998.
11. Knudsen JD, Frimodt-Moller N, Espersen F: Experimental Streptococcus pneumoniae infection in mice for studying correlation of in vitro and in vivo activities of penicillin against pneumococci with various susceptibilities to penicillin. Antimicrob Agents Chemother 39:1253-1258, 1995.
12. Bergeron Y, Ouellet N, Deslauriers AM, Simard M, Olivier M, Bergeron MG: Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice. Infect Immun 66:912-922, 1998.
13. Moine P, Mazoit JX: Streptococcus pneumoniae pneumonia in mice: optimal amoxicillin dosing predicted from a pharmacokinetic-pharmacodynamic model. J Pharmacol Exp Ther 291:1086-1092, 1999.
14. Nuermberger E, Helke K, Bishai WR: Low-dose aerosol model of pneumococcal pneumonia in the mouse: utility for evaluation of antimicrobial efficacy. Int J Antimicrob Agents 26:497-503, 2005.
15. McCafferty DM, Miampamba M, Sihota E, Sharkey KA, Kubes P: Role of inducible nitric oxide synthase in trinitrobenzene sulphonic acid induced colitis in mice. Gut 45:864-873, 1999.
16. Kubes P: Nitric oxide modulates epithelial permeability in the feline small intestine. Am J Physiol 262:G1138-G1142, 1992.
17. Meyrick B, Brigham KL: Acute effects of Escherichia coli endotoxin on the pulmonary microcirculation of anesthetized sheep structure:function relationships. Lab Invest 48:458-470, 1983.
18. Haslett C, Worthen GS, Giclas PC, Morrison DC, Henson JE, Henson PM: The pulmonary vascular sequestration of neutrophils in endotoxemia is initiated by an effect of endotoxin on the neutrophil in the rabbit. Am Rev Respir Dis 136:9-18, 1987.
19. Krawisz JE, Sharon P, Stenson WF: Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 87:1344-1350, 1984.
20. Larsen TS, Belke DD, Sas R, Giles WR, Severson DL, Lopaschuk GD, Tyberg JV: The isolated working mouse heart: methodological considerations. Pflugers Arch 437:979-985, 1999.
21. McBeth PB, Zengerink I, Zygun D, Ranson K, Anderson I, Lall RN, Kirkpatrick AW: Comparison of intermittent and continuous intraabdominal pressure monitoring using an in vitro model. Int J Clin Pract 62:400-405, 2008.
22. Yang S, Chung CS, Ayala A, Chaudry IH, Wang P: Differential alterations in cardiovascular responses during the progression of polymicrobial sepsis in the mouse. Shock 17:55-60, 2002.
23. Gang Y, Malik M: Heart rate variability in critical care medicine. Curr Opin Crit Care 8:371-375, 2002.
24. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29: 1303-1310, 2001.
25. Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:1546-1554, 2003.
26. Doig CJ, Sutherland LR, Sandham JD, Fick GH, Verhoef M, Meddings JB: Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients. Am J Respir Crit Care Med 158:444-451, 1998.
27. Neveu H, Kleinknecht D, Brivet F, Loirat P, Landais P: Prognostic factors in acute renal failure due to sepsis. Results of a prospective multicentre study. The French Study Group on Acute Renal Failure. Nephrol Dial Transplant 11:293-299, 1996.
28. Bagshaw SM, Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, et al.: Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephrol 2:431-439, 2007.
29. Shiohira S, Yoshida T, Shirota S, Tsuchiya K, Nitta K: Protective effect of carbon monoxide donor compounds in endotoxin-induced acute renal failure. Am J Nephrol 27:441-446, 2007.
30. Wu L, Tiwari MM, Messer KJ, Holthoff JH, Gokden N, Brock RW, Mayeux PR: Peritubular capillary dysfunction and renal tubular epithelial cell stress following lipopolysaccharide administration in mice. Am J Physiol Renal Physiol 292:F261-F268, 2007.
31. Parker MM, Shelhamer JH, Bacharach SL, Green MV, Natanson C, Frederick TM, Damske BA, Parrillo JE: Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 100:483-490, 1984.
32. Raper R, Sibbald WJ, Driedger AA, Gerow K: Relative myocardial depression in normotensive sepsis. J Crit Care 4:9-18, 1989.
33. Parker MM, McCarthy KE, Ognibene FP, Parrillo JE: Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest 97:126-131, 1990.